Insights
Essays · Page 5
-
Drug Legalization Series Part 25: Punishing Pain or Saving Lives - The Real Choice in Drug Policy Reform
Part 25 reframes drug policy as punishing pain or saving lives: public health, overdose prevention, treatment on demand, and risk-based regulation.
-
What Is Identity-Based Recovery in Addiction?
What is identity-based recovery? It focuses on who you are becoming, not only behaviors to stop, via three self-identifying steps and ReturnPath beside clinical care.
-
Deepfake Selfies: Why Face Checks Fail
Can deepfake selfies fool identity verification? Yes, when fake faces, voices, and ID images arrive together. How selfie checks work, why they break, and what still holds.
-
The AI Identity Problem: Can AI Agents Hijack Your Digital Identity?
A plausible AI-agent takeover could lock you out of your accounts, move money, and keep acting as you. What is possible now, and how do we prevent it?
-
Drug Legalization Series Part 24: The Ethical Case for Regulation - What We Owe People We Know Will Use Drugs
Part 24 on drug legalization ethics: we owe regulation that cuts preventable death instead of outsourcing safety to a black market when use is inevitable.
-
What Curriculum Can Halfway Houses Use for Reentry Programming?
ReturnPath halfway house reentry curriculum: goals, 16-week modules, process outcomes, workbook accountability, rolling enrollment, facilitator guides.
-
Drug Legalization Series Part 23: What Failure Looks Like If We Don't Change: Projecting the Status Quo Forward
Part 23 models drug overdose death projections under today's laws, showing what failure may look like if we keep the status quo.
-
What Substance Abuse Curriculum Works for IOP and Sober Living?
IOP substance abuse curriculum: goals, 16-week modules with Phase 2 values/identity, process outcomes, ReturnPath daily workbook between group sessions.
-
How to Quit Using Drugs Without Treatment
How do I quit using drugs without treatment? Safety-first steps when rehab is unavailable, you are not ready for formal care, or fear keeps you from asking for help.
-
Drug Legalization Series Part 22: Public Buy-In Is Built, Not Waited For: How Public Opinion Actually Shifts on Uncomfortable Drug Policy
How leaders build public support for drug policy that feels uncomfortable first, and why public perception shapes what lawmakers pass and fund.
-
Drug Legalization Series Part 21: Drug Legalization Is Bipartisan: Political Reality, Not Political Fantasy
Part 21 explains why bipartisan drug policy reform is viable now and why regulated legalization is a public health and safety upgrade, not ideology.
-
Drug Legalization Series Part 20: Urgency Without Panic - Why This Can't Wait Another Decade
Part 20 explains why an overdose prevention strategy can't wait another decade, and lays out urgent, measurable steps that reduce death without panic.
-
Does Drug Legalization Reduce Recidivism?
How does drug legalization affect recidivism? It can cut drug-related arrests and re-incarceration cycles when reform pairs legal access with treatment, housing, and reentry support.
-
Drug Legalization Series Part 19: This Is Already Being Administered - The Myth That Regulation Is Too Complex to Run
Part 19 argues regulation is already administered across health, safety, and controlled-substance systems, and how that capacity can scale responsibly.
-
Drug Legalization Series Part 18: Public Health, Not Moral Panic - Building a Public Health Drug Policy That Actually Reduces Harm
Part 18 makes the case for public health drug policy that replaces moral panic with overdose prevention, harm reduction, and treatment on demand.
-
Drug Legalization Series Part 17: Drug Decriminalization Case Studies: What Worked and What Failed
Part 17 reviews drug decriminalization case studies across the U.S. and abroad to show what worked, what failed, and why, without cherry-picking.
-
Drug Legalization Series Part 16: How to Run a Drug Legalization Pilot Program Without Betting the Farm
Part 16: a drug legalization pilot framework, risk-based regulation, measured outcomes, diversion control, privacy, and results-based funding.
-
Drug Legalization Series Part 15: Arguments Against Drug Legalization: The Hard Objections, Answered Directly
The strongest arguments against drug legalization deserve direct answers, pros and cons, youth access, public safety, and whether use rises.
-
Drug Legalization Series Part 14: A Regulated Pharmacy Model for High-Risk Substances
A regulated pharmacy model for high-risk substances could replace street chaos with standards, cut overdose risk, and connect people to treatment fast.
-
Drug Legalization Series Part 13: Mental Health, Housing, and Despair
Part 13 explores drug addiction and homelessness, mental illness, and housing-first recovery in the drug legalization and regulation series.